Abstract:The connection of two or more proteins with different binding specificities or activities can lead to unique and powerful systems with significant potential in therapeutic applications, particularly oncology. While a plethora of active bifunctional proteins have been produced by fusion, this approach is not always viable, since modification of the N- or C- terminus can compromise the proteins’ bioactivities, with complications during folding and processing often being observed. Chemical cross-linking can offer a more versatile strategy towards the synthesis of protein-protein conjugates. However, current state-of-the-art approaches are either not selective, yielding heterogeneous mixtures or require mutations with natural or unnatural amino acids, which are often associated with low expression yields and limited applicability towards all protein systems. Recently, a bis-dibromomaleimide cross-linking reagent was used to create a bispecific scFv-Fab antibody in a site-specific manner, by targeting and bridging disulfide bonds. In this work, the application of these cross-linking reagents was extended into the conjugation of proteins containing different reactive handles, as well as sterically hindered conjugation sites. Diiodo-maleimides were shown to offer the ideal properties of rapid bioconjugation and importantly, reduced hydrolysis, which was identified as a significant factor affecting the conjugation efficiency. The optimized linkers were exploited to link human serum albumin to antibody fragments (scFv and Fab) as a prospective half-life extension platform, with retention of antigen binding and robust serum stability. The linker design was also extended to incorporate a third point of attachment for another biomolecule. An anti-CEA scFv homotrimer was formed, by disulfide bridging, which was shown to infer a combination of greater antigen avidity and increased in vivo half-life. Finally, with the view to developing a Bispecific T-cell Engager (BiTE) construct that could lead to more efficient cell-killing, an anti-CEA/ anti-CD3 scFv heterotrimer of increased avidity towards CD3 antigen was developed, showing the potential of this strategy for the construction of a diverse range of bioconjugates. The last part of this thesis describes investigations towards the development of a new methodology that selectively modifies specific lysine residues, via acyl transfer from the disulfide bond of Fab antibody fragment. This approach is expected to complement disulfide bridging as a strategy for selective modification, but also be advantageous for systems where this could result in detrimental changes to the antibody structure, offering a highly promising platform for bioconjugation.

Identification of Styryl Sulfonyl Fluoride As a Near-Perfect Michael Acceptor for Diversified Protein Bioconjugations

Identification of Styryl Sulfonyl Fluoride (SSF) as An Efficient, Robust and Irreversible Cysteine-specific Protein Bioconjugation Reagent

Redox-Based Reagents for Chemoselective Methionine Bioconjugation

Cysteine-specific Protein Multi-Functionalization and Disulfide Bridging Using 3-Bromo-5-methylene Pyrrolones

Sulfoxide-mediated Cys-Trp-selective bioconjugation that enables protein labeling and peptide heterodimerization

One Stone Two Birds: beta-Fluoropyrrolyl-Cysteine SNAr Chemistry Enabling Functional Porphyrin Bioconjugation

Sulfa-Michael Addition on Dehydroalanine: A Versatile Reaction for Protein Modifications

Two Birds One Stone: Β-Fluoropyrrolyl-cysteine SNAr Chemistry Enabling Functional Porphyrin Bioconjugation

Biocompatible SuFEx Click Chemistry: Thionyl Tetrafluoride (sof4)‐derived Connective Hubs for Bioconjugation to DNA and Proteins

Site-Selective S-gem-Difluoroallylation of Unprotected Peptides with 3,3-Difluoroallyl Sulfonium Salts

Stoichiometric and irreversible cysteine-selective protein modification using carbonylacrylic reagents

Enantioselective Synthesis of Chiral Sulfonimidoyl Fluorides Facilitates Stereospecific SuFEx Click Chemistry

Thiol Specific and Tracelessly Removable Bioconjugation Via Michael Addition to 5-Methylene Pyrrolones

Chemoselective Fluorogenic Bioconjugation of Vicinal Dithiol-Containing Proteins for Live Cellular Imaging Via Small Molecular Conjugate Acceptors.

New Strategies for Cysteine Bioconjugation and Protein Cross-Linking

A Sulfonium Tethered Peptide Ligand Rapidly and Selectively Modifies Protein Cysteine in Vicinity

Multifluorinated Aryl Azides for the Development of Improved H2S Probes, and Fast Strain‐promoted Azide‐Alkyne Cycloaddition and Staudinger Reactions

Facile preparation of sulfonium peptide and protein probes for selective crosslinking of methyllysine readers

β-Carbonyl sulfonium enables cysteine-specific bioconjugation for activity-based protein profiling in live cells

Kinetic Assay of the Michael Addition-Like Thiol-Ene Reaction and Insight into Protein Bioconjugation

Protein Encapsulation: a New Approach for Improving the Capability of Small-Molecule Fluorogenic Probes